ALEXIS CATANIA: Open Payments
NPI 1740828649 · YORKTOWN HTS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,915 in 258 payments from 23 companies in 2025. Trend: 2023 $2,763 · 2024 $3,332 · 2025 $4,915
Food & beverage: $4,915
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 42 | $654 |
| ABBVIE INC. | 18 | $463 |
| E.R. Squibb & Sons, L.L.C. | 20 | $396 |
| Janssen Pharmaceuticals, Inc | 17 | $385 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $382 |
| Neurocrine BioSciences, Inc. | 12 | $345 |
| Teva Pharmaceuticals USA, Inc. | 18 | $325 |
| Otsuka America Pharmaceutical, Inc. | 18 | $323 |
| Alkermes, Inc. | 16 | $293 |
| Vanda Pharmaceuticals Inc. | 12 | $232 |
Products named: REXULTI, VRAYLAR, COBENFY, CAPLYTA, SPRAVATO, INGREZZA, ARISTADA, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
